Acapela Group

Acapela Group is a leading developer of voice synthesis and text-to-speech (TTS) technologies, specializing in healthcare and assistive communication solutions. The company is widely recognized for its "my-own-voice" platform, which allows individuals with degenerative conditions like Amyotrophic Lateral Sclerosis (ALS) to record and preserve their natural voice before losing the ability to speak. This digital voice is then integrated into Augmentative and Alternative Communication (AAC) devices, enabling patients to maintain their personal identity and communicate more effectively. Acapela's technology utilizes advanced neural speech synthesis to create highly natural and expressive voices in dozens of languages. In 2022, the company was acquired by Tobii Dynavox, the global leader in assistive technology, to enhance their portfolio of communication aids.